Catherine Offord

Catherine Offord

After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science writer. She has worked in various guises at The Scientist, starting as an intern in early 2016 before becoming a correspondent. As associate editor, she now writes articles for the online and print publications, and edits the magazine’s Notebook, Careers, and Bio Business sections.

Articles by Catherine Offord
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
Catherine Offord | May 27, 2020
A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.
Cal State University to Conduct Most Classes Online this Fall
Cal State University to Conduct Most Classes Online this Fall
Catherine Offord | May 13, 2020
The public university system in California joins a number of colleges planning a virtual semester to minimize the risk of spreading COVID-19.
Paul Marks, Past President of MSKCC, Dies
Paul Marks, Past President of MSKCC, Dies
Catherine Offord | May 8, 2020
A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.
How Time Is Encoded in Memories
How Time Is Encoded in Memories
Catherine Offord | May 1, 2020
Rats and equations help researchers develop a theory of how our brains keep track of when events took place.
Infographic: How the Brain Keeps Track of Time in Memories
Infographic: How the Brain Keeps Track of Time in Memories
Catherine Offord | May 1, 2020
Signals from the lateral entorhinal cortex help create “time cells” in the hippocampus, according to some researchers.
Remdesivir Shows Promise in Largest of Several Clinical Trials
Remdesivir Shows Promise in Largest of Several Clinical Trials
Catherine Offord | Apr 30, 2020
Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.
special report
How (Not) to Do an Antibody Survey for SARS-CoV-2
How (Not) to Do an Antibody Survey for SARS-CoV-2
Catherine Offord | Apr 28, 2020
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.
First US COVID-19 Deaths Happened Weeks Earlier than Thought
First US COVID-19 Deaths Happened Weeks Earlier than Thought
Catherine Offord | Apr 22, 2020
Autopsies recently carried out in California show that one person died of the disease on February 6—three weeks before the nation recorded its first fatality.
Geneticist Drops Out of New Role After Allegations of Gender Bias
Geneticist Drops Out of New Role After Allegations of Gender Bias
Catherine Offord | Apr 9, 2020
Constantine Stratakis, who was due to lead an institute at McGill University Health Centre, was the subject of eight equal employment opportunity complaints at his last job at the National Institute of Child Health and Human Development.
HIV Researcher Gita Ramjee Dies of Complications Tied to COVID-19
HIV Researcher Gita Ramjee Dies of Complications Tied to COVID-19
Catherine Offord | Apr 1, 2020
The South African scientist fought for women’s access to healthcare in disadvantaged communities.